FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / sales-compensation-analysis.docx
sales-compensation-analysis.docx · 1037-00003

Parties

Harkness LLP
Solstice Biomedical Inc
Solstice Biomedical Devices Ltd
Meridian Consulting Group LLC
Launch Solstice Biomedical Devices Ltd
Vantage Medical Technologies Inc
Ascendant Distribution Solutions LLC
Organization Structure Solstice Biomedical Inc

Dates

July 18, 2024
October 1, 2024
January 22, 2024
February 9, 2024
December 31, 2025
March 15, 2024

Amounts

$4,950
$1,200
$26
$4.68
$100,000
$13,946
$27,894
$95,000
$115,000
$90,000

Obligations

Accordingly, any compensation arrangement that involves the sale or promotion of Pulsar™ devices — including the sales compensation plan under review — must be evaluated for AKS compliance
The individual receiving compensation must be a bona fide employee of the entity making the payment, as established by the common-law test of employment under the Internal Revenue Code (i
The employee must be engaged in employment that involves the furnishing of items or services for which payment may be made under a federal healthcare program
Two important limitations on the scope of the safe harbor must be noted: First, the employee safe harbor does not apply to independent contractor sales representatives
Solstice must ensure that no territory managers or other sales personnel are classified as 1099 independent contractors